Use of flibanserin in the treatment of sexual disorders
Details for Australian Patent Application No. 2002333894 (hide)
International Classifications
Event Publications
13 February 2003 Complete Application Filed
Priority application(s): 01125020.6 20.10.01 EP
3 July 2003 Application Open to Public Inspection
Published as AU-B-2002333894
1 November 2007 Application Accepted
Published as AU-B-2002333894
28 February 2008 Standard Patent Sealed
30 August 2012 Assignment Registered
Boehringer Ingelheim Pharma GmbH & Co. KG The patent has been assigned to Sprout Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002333895-Methods for preventing and treating bone loss with steroid compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser